SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Arvind Remedies declines as its production disrupts at Kakkalur unit

06 Jan 2015 Evaluate

Arvind Remedies is currently trading at Rs. 30.55, down by 0.90 points or 2.86% from its previous closing of Rs. 31.45 on the BSE.

The scrip opened at Rs. 31.40 and has touched a high and low of Rs. 31.95 and Rs. 30.25 respectively. So far 156060 shares were traded on the counter.

The BSE group 'B ' stock of face value Rs. 10 has touched a 52 week high of Rs. 66.05 on 08-Sep-2014 and a 52 week low of Rs. 23.25 on 18-Dec-2014.

Last one week high and low of the scrip stood at Rs. 32.45 and Rs. 28.50 respectively. The current market cap of the company is Rs. 207.10 crore.

The promoters holding in the company stood at 36.40% while Institutions and Non-Institutions held 1.88% and 61.72% respectively.

Arvind Remedies production has been affected since there has been strike by the workers of the company in Unit No 1 at Kakkalur. The strike has been effective since few days on account of raising their demands. The management has initiated conciliation efforts and hopes to bring back normalcy at the earliest.

Arvind Remedies is engaged in the manufacturing of pharmaceutical formulations such as tablets, capsules (including soft gels), ointments and liquids. ARL markets its products in the institutional (primarily government organizations) and ethical segments, with institutional segment contributing to 70% of the total revenues.

 

Peers
Company Name CMP
Sun Pharma Inds. 1653.60
Dr. Reddys Lab 1224.05
Cipla 1213.90
Zydus Lifesciences 928.00
Lupin 2325.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×